Top Markets
Coin of the day
Oxurion N.V. Oxurion N.V.

Oxurion N.V.

OXUR
Clasificación en acciones #39566
Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a... Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a biopharmaceutical firm focused on researching, developing, and bringing to market treatments for various ocular conditions worldwide. Its primary commercialized offering is JETREA, a medication used to address vitreomacular adhesion and vitreomacular traction. The company's development pipeline includes THR-149, a plasma kallikrein inhibitor currently undergoing Phase II clinical trials for diabetic macular edema (DME), and THR-687, an integrin antagonist also in Phase II trials for DME. Oxurion has forged strategic partnerships with Bicycle Therapeutics, INC Research, and Galapagos NV. The organization was formerly known as ThromboGenics NV before officially changing its name to Oxurion NV in September 2018.
Precio por acción
$0.003084
Capitalización bursátil
$434.03K
Cambio (1 día)
-7.14%
Cambio (1 año)
-89.24%
País
BE
Comercio Oxurion N.V. (OXUR)

Categoría

Historial de desdoblamientos de acciones de Oxurion N.V. (OXUR)
La acción Oxurion N.V. (símbolo: OXUR) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 14, 2026.
Una acción OXUR comprada antes de Aug 14, 2026 equivaldría hoy a 0 acciones OXUR.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE